Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer

By Solomon B.   Ball D.L.   Richardson G.   Smith J.G.   Millward M.   MacManus M.   Michael M.   Wirth A.   O'Kane C.   Muceniekas L.   Ryan G.   Rischin D.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite

Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer

By Cappuzzo F.   De Marinis F.   Nelli F.   Calandri C.   Maestri A.   Benedetti G.   Migliorino M.R.   Cortesi E.   Rastelli F.   Martelli O.   Andruccetti M.   Bartolini S.   Crino L.  

Lung Cancer, Vol. 42, Iss. 3, 2003-12 ,pp. : 355-361

Elsevier

Access to resources Recommend Favorite

Phase I/II Trial of Paclitaxel and Vinorelbine in Advanced Non-Small Cell Lung Cancer

By Grunberg Steven   Dugan Matthew   Greenblatt Marc   Ospina David   Valentine John  

Cancer Investigation, Vol. 23, Iss. 5, 2005-07 ,pp. : 392-398

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer - results of the EORTC 08912 phase I/II study

By Uitterhoeve A.L.J.   Belderbos J.S.A.   Koolen M.G.J.   van der Vaart P.J.M.   Rodrigus P.T.R.   Benraadt J.   Koning C.C.M.   Gonzalez Gonzalez D.   Bartelink H.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 592-600

Elsevier

Access to resources Recommend Favorite

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

By Koukourakis M.I.   Kourousis C.   Kamilaki M.   Koukouraki S.   Giatromanolaki A.   Kakolyris S.   Kotsakis A.   Androulakis N.   Bahlitzanakis N.   Georgoulias V.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite